Synaptic Plasticity-Regulated Gene Expression: a Key Event in the Long-Lasting Changes of Neuronal Function
Author:
Open Access
- 1 January 2008
- journal article
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 31 (3) , 327-335
Abstract
“Neuronal activity”-dependent transcriptional activation is required for the long-lasting, functional changes that are involved in memory consolidation or drug addiction. Elucidation of the molecular mechanisms underlying the neuronal activity-dependent transcription of synaptic plasticity-related genes has helped towards understanding neuronal function and disorders as well in identifying new target molecules for drug design. In this study, we focused on neurotrophin and neuropeptide, which both have the ability to modulate neuronal survival and function. We also examined the molecular mechanisms by which underlying neurotrophin genes are regulated by neuronal activity. Brain-derived neurotrophic factor (BDNF) is a neurotrophin family member that has important roles in neuronal survival and plasticity as well as in psychiatric disorders. Transcriptional activation of the BDNF gene is commonly regulated by a key transcription factor, cAMP response element-binding protein (CREB), and this at least in part contributes to neuronal activity-dependent neuronal survival. Among at least four distinct promoters of the BDNF gene, promoters I and III are differentially activated by Ca2+ signals via NMDA receptors and L-type voltage-dependent Ca2+ channels. Especially, BDNF gene promoter I activation requires the cooperative binding of and upstream stimulatory factor (USF) and CREB to a CRE/USF binding site. By contrast, NT-3 gene transcription is regulated by Sp3/4. An important future direction will be to elucidate how long-lasting changes in neuronal plasticity are “epigenetically” and “structurally” controlled. Our studies on the relationships between long-lasting neuronal responses and gene expressions should help guide research into novel drugs for neuronal or psychiatric disorders.Keywords
This publication has 58 references indexed in Scilit:
- Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promotersGenomics, 2007
- Mouse and rat BDNF gene structure and expression revisitedJournal of Neuroscience Research, 2006
- Genomic DNA methylation: the mark and its mediatorsTrends in Biochemical Sciences, 2006
- Activity-dependent Transcriptional Activation and mRNA Stabilization for Cumulative Expression of Pituitary Adenylate Cyclase-activating Polypeptide mRNA Controlled by Calcium and cAMP Signals in NeuronsJournal of Biological Chemistry, 2004
- Epigenetic programming by maternal behaviorNature Neuroscience, 2004
- REST4-Mediated Modulation of REST/NRSF-Silencing Function during BDNF Gene Promoter ActivationBiochemical and Biophysical Research Communications, 2002
- Silencer-Mediated Repression and Non-Mediated Activation of BDNF and c-fos Gene Promoters in Primary Glial or Neuronal CellsBiochemical and Biophysical Research Communications, 1999
- Activity-dependent Expression of Parathyroid Hormone-related Protein (PTHrP) in Rat Cerebellar Granule NeuronsJournal of Biological Chemistry, 1997
- Regulation of the Rat p75 Neurotrophin Receptor Promoter by GC Element Binding ProteinsBiochemical and Biophysical Research Communications, 1996
- Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cellsBiochemical and Biophysical Research Communications, 1989